To be sure, resource management has to factor in somewhere...but Afrezza advocates are not even at the table. you and I are fortunate to have means of circumventing coverage or lack thereof. If Afrezza saves lives, as I think could eventually be proven if it can simultaneously improve adherence and reduce hypos, there will be no denying it. One slip with injected insulin and you are dead. Mistakes with Afrezza (early user expereince) are more forgiving. Seems a no-brainer to me.
There is a group in Berkeley Ca, former and present day Biotech staffers, building a GMO insulin "home brew" facility. The next step after that is bootleg TS insulin. Its complex, but I know its not rocket science. Some folks are pretty scientific about their home brew - me among them!